We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
G0-man, if you are referring to me then why do you assume I "hate" avct?
I can't tell you how strong the emotions seem to run on here on this stock. Its crazy and its not helpful when trying to make rational decisions or points.
It doesn't make any difference to you or the SP whatever anyone else thinks or does.
If the LFT is selling millions per month then the SP will move up very sharply when the market hears about it. Whether you believe it is, or I believe it isn't, won't affect the outcome, will it?
If you believe that posts that are not fulsome in assuming every positive spin on AVCT hurts the SP, it can't hurt it very much can it ? a penny or two?
We have just had a glowing report from Myles who has a tremendous following on social media and he has not moved the dial more than a penny, so really what difference do you think my view makes?
As far as I am aware we are not using ABDX yet to produce any test.
I have no handle on sales or profit margin per test yet. Therefore as this is absolutely key financial info, I will assume that its not ready to be divulged. I further conclude, given if it was a "positive story" then that info would be now in the public forum and as its not I assume sales/profit are still on the low side of expectations ie up to a million per month.
If Avacta weren't selling these tests in bulk, do you really think they would have upped their manufacturing with Abingdon and be looking to upscale even more?
Come on guy, your deramping arguments are just pathetic now. If you don't think there's value in Avacta then sell on and move out. This forum is for investors and like me, most investors invest in a company because they believe in where they're going.
Christ knows why those of you who seem to hate Avacta are still here spouting the same nonsense day after day.
Ok, you seem a bit weird Ice, so if its alright with you I'll give you a miss from now on.
You seem a bit emotionally caught up with me and are more concerned on my financial acumen and gardening prowess than being able to look objectively at whether or not AVCT is selling more or less tests through bio-serve.
Each cog in the AVCT growth story has its own responsibility and a specific one needs to pursue a specific strategy which respects the whole hence a new update, 2 months after the last to further the establishment of affimers as mainstream biotech.
Windy don’t need an essay to tell us you want to buy back in cheaper!! I will point out Bioserve have a reputation to maintain if they are promoting the relationship on LinkedIn!! they are very happy with the sales and feedback of AVCT test! We will find out though in due course!! P.S I suggest you spend less time writing essays and more time cutting your 60ft tree’s!! Prob 80ft now haha
Thanks for your thoughts and well wishes Ice, Don't know quite what I have done to you but hey ho, long as you are happy.
"Obviously the relationship is going very well and they are selling loads of tests!! Actually checking the website they are promoting the test a lot"
What makes you assume they are selling loads of tests ? It could it also be that they are not selling very many and need to kick start sales?
For instance if they were selling loads they could have put on the website. Something like "due to high demand for this we have secured extra supply so order now .." That would potentially reassure new customers that this was a "good" or popular test.
To simply reiterate what has gone before ie they supply the test does not give me the same warm feeling as it clearly gives you.
I don't know which one it is but given that as far as we can tell capacity has not been increased otherwise we would have been told, I am not assuming it is as good as you think . (Is ABDX finished TT and is now making our tests? looking at their SP I would say not.)
This is the bit that’s important!!!
BioServUK (a Calibre Scientific, Inc. company) continues its successful partnership with Avacta Life Science in distributing their high-performance AffiDX® SARS-CoV-2 Lateral Flow Test.
Obviously the relationship is going very well and they are selling loads of tests!! Actually checking the website they are promoting the test a lot. Reading your posts today wind I think you are out of Avct and if I didn’t know any better you want a low buy back in price!! Hopefully you get burned!!
Roundhowe, It was a genuine question as Poirot is pretty good at lateral links, but I can't see how this is different to when Bioserve was RNS'd as a supplier months ago and given people are reacting to his post saying good spot etc etc, it sounds like this is new and significant so I just wondered what it is i am missing.
if nothing has changed and they have just altered the wording or the position on their website, is it just the suggestion they are trying to generate more sales?
wyndrum…..it’s called marketing.
Nice find Poirot
Poirot,
What am i missing?
What does this tell us that we did no know months ago? (Just enquiring as this is old news isn't it?)
Thanks in advance
Nice post poirot. Well pointed out ND.
BioServUK (a Calibre Scientific, Inc. company) continues its successful partnership with Avacta Life Science in distributing their high-performance AffiDX® SARS-CoV-2 Lateral Flow Test which is developed and manufactured in the UK, based on their proprietary Affimer® technology.
Top Features of the Lateral Flow Test:
- 98% sensitivity
- 99% specificity
- CE IVD marked
- MHRA registered
- Patient-friendly: Anterior nares (nasal) swabs samples for a more comfortable collection
- Monitored against emerging Variants: Proven to detect the new Delta variant (B.1.617.2) as per a recent study
- Rapid & Simple: Easy to use, simple work-flow, results in only 20 minutes
Ordering Information:
Product code: BSV-COV-11711125
Product name: AffiDX® SARS-CoV-2 Antigen Lateral Flow Test
Pack size: 1 Pack (25 Tests)
https://lnkd.in/g9YfCrk
info@BioServUK.com
+44 (0)114 224 2235
#bioservuk #avacta #calibrescientific #covid19testing #covid19pandemic #covid19awareness #covid19response #sarscov2 #covid #covid19news #lifesciences #biotechnology #viruses #lateralflowtest #covidtesting #pandemic #pcrtest
https://www.linkedin.com/posts/bioservuk_bioservuk-avacta-calibrescientific-activity-6858723046883237889-vcHo